A detailed history of Pnc Financial Services Group, Inc. transactions in Sana Biotechnology, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 20 shares of SANA stock, worth $47. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20
Previous 20 -0.0%
Holding current value
$47
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$5.23 - $10.44 $67 - $135
13 Added 185.71%
20 $0
Q1 2024

May 10, 2024

BUY
$4.2 - $11.27 $29 - $78
7 New
7 $0
Q1 2022

May 12, 2022

SELL
$5.24 - $15.58 $235 - $701
-45 Reduced 6.98%
600 $4,000
Q3 2021

Nov 05, 2021

SELL
$16.29 - $25.88 $9,040 - $14,363
-555 Reduced 46.25%
645 $14,000
Q2 2021

Aug 06, 2021

BUY
$16.65 - $32.14 $9,990 - $19,284
600 Added 100.0%
1,200 $23,000
Q1 2021

May 07, 2021

BUY
$23.04 - $43.5 $13,824 - $26,100
600 New
600 $20,000

Others Institutions Holding SANA

About Sana Biotechnology, Inc.


  • Ticker SANA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 190,232,000
  • Market Cap $447M
  • Description
  • Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, genetic disorders, and others...
More about SANA
Track This Portfolio

Track Pnc Financial Services Group, Inc. Portfolio

Follow Pnc Financial Services Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.